Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogenic Bone Marrow Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00008450
What this trial is testing

Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant

Who this might be right for
Adenosine Deaminase DeficiencyAutosomal Recessive DisorderImmune System Disorder+4 more
Fred Hutchinson Cancer Center 6
Early research (Phase 1)Active Not RecruitingNCT03560752
What this trial is testing

CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant

Who this might be right for
Accelerated Phase CML, BCR-ABL1 PositiveAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+11 more
City of Hope Medical Center 34
Testing effectiveness (Phase 2)Study completedNCT00146055
What this trial is testing

Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood

Who this might be right for
Myeloma, Plasma-CellLymphoma, MalignantMyeloproliferative Disorders+2 more
University of Michigan Rogel Cancer Center 60
Early research (Phase 1)Study completedNCT03600155
What this trial is testing

Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia+1 more
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT01280955
What this trial is testing

Donor Enhancement With Plerixafor Post Myeloablative Allogeneic Transplant

Who this might be right for
Failure of Bone Marrow Graft
Mitchell Horwitz, MD 41
Early research (Phase 1)WithdrawnNCT03939585
What this trial is testing

Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT

Who this might be right for
Allogeneic Stem Cell Transplant CandidateAcute Myeloid/Lymphoblastic LeukemiaMyelodysplastic Syndrome+2 more
Leland Metheny
Testing effectiveness (Phase 2)Study completedNCT00027547
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00824993
What this trial is testing

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

Who this might be right for
Hematological Malignancies
M.D. Anderson Cancer Center 78
Early research (Phase 1)Active Not RecruitingNCT04980404
What this trial is testing

Inqovi Maintenance Therapy in Myeloid Neoplasms

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaStem Cell Leukemia
Massachusetts General Hospital 22
Testing effectiveness (Phase 2)Study completedNCT02294552
What this trial is testing

Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaLymphoma+3 more
Ivan S Moiseev 200
Early research (Phase 1)Study completedNCT02917096
What this trial is testing

Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis

Who this might be right for
Primary MyelofibrosisSecondary Myelofibrosis
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT01573182
What this trial is testing

Herpes Zoster Vaccine for Bone Marrow Transplant Donors

Who this might be right for
Herpes Zoster
University of Sydney 8
Early research (Phase 1)Looking for participantsNCT07302776
What this trial is testing

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

Who this might be right for
GVHDHematopoietic Cell Transplantation (HCT)Acute Myeloid Leukemia (AML)+4 more
Stanford University 50
Testing effectiveness (Phase 2)Looking for participantsNCT05775718
What this trial is testing

Shingrix In Recipients of Allogeneic Transplants

Who this might be right for
Bone Marrow TransplantStem Cell Transplant
University of Colorado, Denver 55
Testing effectiveness (Phase 2)Looking for participantsNCT04282187
What this trial is testing

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Who this might be right for
Acute Myeloid LeukemiaEssential ThrombocythemiaMyelodysplastic Syndrome+6 more
University of Washington 25
Large-scale testing (Phase 3)UnknownNCT03655145
What this trial is testing

HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyeloproliferative Syndromes+1 more
Assistance Publique - Hôpitaux de Paris 344
Testing effectiveness (Phase 2)Ended earlyNCT00720629
What this trial is testing

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 8
Not applicableStudy completedNCT00510315
What this trial is testing

Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant

Who this might be right for
LeukemiaHodgkin's LymphomaNon-Hodgkin's Lymphoma+1 more
Memorial Sloan Kettering Cancer Center 11
Not applicableLooking for participantsNCT05579678
What this trial is testing

APOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation

Who this might be right for
Allogeneic Disease
University of Alberta 45
Testing effectiveness (Phase 2)Looking for participantsNCT05126849
What this trial is testing

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression

Who this might be right for
Refractory Idiopathic Aplastic AnemiaHaploidentical Allogeneic Hematopoietic Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 31
Next Page